I have written short summary note on Strides Shasunâs FY17 Annual Report.
I hope this will be helpful to you.
PS: Please find the attachment.Strides Shasun Ltd AR 2017 Key Highlights.pdf (702.4 KB)
Thanks & regards,
Rushin Shah
We should hopefully have a bottom now - The dissonance doesnât make sense - Good operational numbers and the stock at a 52 week low - Similar situation with Sequent. Downside is probably limited now
@Wolf nice summary of the day âŚwould you be able to share the url if this is from some website? else source please?
expecting a better (direct) link for the market summary oneâŚ
I know of the first one (bseindia one http://www.bseindia.com/corporates/Insider_Trading_new.aspx)âŚ
Yes, my apologies
Pls scroll down to âinsider tradesâ
Strides still getting hammered!
How it impacts business of both the companies? Was it good for Eris or Strides? Any comments from fellow boarders who follows any one of these companies?
SBI MF used the opportunity (low price) to add up more than 2% shares of STARâŚ
Surprised to see hdfc sec give two buy recommendations within the same month!
http://www.bseindia.com/corporates/shpPublicShareholder.aspx?scripcd=532531&qtrid=96.00&QtrName=December%202017
You were right âŚwould be glad if your could share how you knew it so surely?
Looking at december 2017 SHPâŚI see almost all MF houses increased their stakeâŚseems like an opportunity to add more?
Through my sources in the market
The debt at 3700 cr is on the higher side. Interest payments are above 60 cr per quarter. This is approx 60 percent of the operating profit. Either they profits have to increase dramatically or they have took took so of units to pare down debt. Either way this could take time and this is reflecting in the share price.
Why the stock is going down even when it is managing to get USFDA approvals?
Is it because of divesting?